Bioavailability Study of Psilocybin in Normal Adults
Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to compare an oral dose of psilocybin and an
intravenous (IV) infusion of psilocybin to assess differences in how the drug is absorbed by
the body, the psychedelic experience, and any side effects when taken by healthy adult
participants. Participants can expect to be in the study for approximately 12 weeks.